These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis? Holers VM Semin Arthritis Rheum; 2024 Feb; 64S():152324. PubMed ID: 38030540 [TBL] [Abstract][Full Text] [Related]
3. Pre-RA: Can early diagnosis lead to prevention? Haville S; Deane KD Best Pract Res Clin Rheumatol; 2022 Mar; 36(1):101737. PubMed ID: 34991984 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis. Bergstedt DT; Tarter WJ; Peterson RA; Feser ML; Parish MC; Striebich CC; Demoruelle MK; Moss L; Bemis EA; Norris JM; Holers VM; Edison JD; Thiele GM; Mikuls TR; Deane KD Front Immunol; 2022; 13():916277. PubMed ID: 35812446 [TBL] [Abstract][Full Text] [Related]
12. The Natural History of Rheumatoid Arthritis. Deane KD; Holers VM Clin Ther; 2019 Jul; 41(7):1256-1269. PubMed ID: 31196652 [TBL] [Abstract][Full Text] [Related]
13. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis. Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946 [TBL] [Abstract][Full Text] [Related]
14. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity. Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001 [TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events. Gouze H; Aegerter P; Said-Nahal R; Zins M; Goldberg M; Morelle G; Schett G; Breban M; D'Agostino MA Arthritis Res Ther; 2022 Feb; 24(1):56. PubMed ID: 35209936 [TBL] [Abstract][Full Text] [Related]
16. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example. Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250 [TBL] [Abstract][Full Text] [Related]
18. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
19. Mucosa Biology and the Development of Rheumatoid Arthritis: Potential for Prevention by Targeting Mucosal Processes. Demoruelle MK Clin Ther; 2019 Jul; 41(7):1270-1278. PubMed ID: 31196643 [TBL] [Abstract][Full Text] [Related]
20. Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis. Sohn DH; Rhodes C; Onuma K; Zhao X; Sharpe O; Gazitt T; Shiao R; Fert-Bober J; Cheng D; Lahey LJ; Wong HH; Van Eyk J; Robinson WH; Sokolove J Arthritis Rheumatol; 2015 Nov; 67(11):2877-87. PubMed ID: 26227989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]